Document Preview Unavailable
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease
Layton, J. Bradley; Ziemiecki, Ryan; Johannes, Catherine B; Pladevall-Vila, Manel; Khan, Anam M; et al. Diabetes Therapy Vol. 16, Iss. 8, (Aug 2025): 1597-1614.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library




